{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:52:24Z","timestamp":1659091944717},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T00:00:00Z","timestamp":1332547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10529-012-0896-5","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T18:17:40Z","timestamp":1332526660000},"page":"1193-1201","source":"Crossref","is-referenced-by-count":7,"title":["Construction and expression of humanized chimeric T cell receptor specific for chronic myeloid leukemia cells"],"prefix":"10.1007","volume":"34","author":[{"given":"Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"issue":"4","key":"896_CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","volume":"26","author":"ME Dudley","year":"2003","unstructured":"Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA (2003) Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 26(4):332\u2013342","journal-title":"J Immunother"},{"issue":"2","key":"896_CR2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","volume":"90","author":"Z Eshhar","year":"1993","unstructured":"Eshhar Z, Waks T, Gross G, Schindler DG (1993) Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci USA 90(2):720\u2013724","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"896_CR3","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1182\/blood-2004-09-3737","volume":"105","author":"D Friedmann-Morvinski","year":"2005","unstructured":"Friedmann-Morvinski D, Bendavid A, Waks T, Schindler D, Eshhar Z (2005) Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood 105(8):3087\u20133093","journal-title":"Blood"},{"issue":"4","key":"896_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/10428190801927510","volume":"49","author":"F Guilhot","year":"2008","unstructured":"Guilhot F, Roy L, Saulnier PJ, Guilhot J, Barra A, Gombert JM, Turhan A (2008) Immunotherapeutic approaches in chronic myelogenous leukemia. Leuk Lymphoma 49(4):629\u2013634","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"896_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00113-2","volume":"3","author":"WY Ho","year":"2003","unstructured":"Ho WY, Blattman JN, Dossett ML, Yee C, Greenberg PD (2003) Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 3(5):431\u2013437","journal-title":"Cancer Cell"},{"issue":"11","key":"896_CR6","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.167.11.6123","volume":"167","author":"A Hombach","year":"2001","unstructured":"Hombach A, Wieczarkowiecz A, Marquardt T, Heuser C, Usai L, Pohl C, Seliger B, Abken H (2001) Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28\/CD3 zeta signaling receptor molecule. J Immunol 167(11):6123\u20136131","journal-title":"J Immunol"},{"issue":"1","key":"896_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","volume":"20","author":"J Maher","year":"2002","unstructured":"Maher J, Brentjens RJ, Gunset G, Riviere I, Sadelain M (2002) Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta\/CD28 receptor. Nat Biotechnol 20(1):70\u201375","journal-title":"Nat Biotechnol"},{"issue":"6","key":"896_CR8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","volume":"22","author":"MY Mapara","year":"2004","unstructured":"Mapara MY, Sykes M (2004) Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol 22(6):1136\u20131151","journal-title":"J Clin Oncol"},{"key":"896_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","volume":"74","author":"FM Marincola","year":"2000","unstructured":"Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74:181\u2013273","journal-title":"Adv Immunol"},{"issue":"5","key":"896_CR10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002620100192","volume":"50","author":"BE Power","year":"2001","unstructured":"Power BE, Caine JM, Burns JE, Shapira DR, Hattarki MK, Tahtis K, Lee FT, Smyth FE, Scott AM, Kortt AA, Hudson PJ (2001) Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector. Cancer Immunol Immunother 50(5):241\u2013250","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"896_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","volume":"111","author":"K Rezvani","year":"2008","unstructured":"Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J, Jafarpour B, Boss C, Barrett AJ (2008) Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood 111(1):236\u2013242","journal-title":"Blood"},{"issue":"1","key":"896_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymthe.2004.04.014","volume":"10","author":"C Rossig","year":"2004","unstructured":"Rossig C, Brenner MK (2004) Genetic modification of T lymphocytes for adoptive immunotherapy. Mol Ther 10(1):5\u201318","journal-title":"Mol Ther"},{"issue":"12","key":"896_CR13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.exphem.2006.07.009","volume":"34","author":"M Schmitt","year":"2006","unstructured":"Schmitt M, Li L, Giannopoulos K, Chen J, Brunner C, Barth T, Schmitt A, Wiesneth M, Dohner K, Dohner H, Greiner J (2006) Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules. Exp Hematol 34(12):1709\u20131719","journal-title":"Exp Hematol"},{"issue":"16","key":"896_CR14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.gt.3301253","volume":"7","author":"RA Willemsen","year":"2000","unstructured":"Willemsen RA, Weijtens ME, Ronteltap C, Eshhar Z, Gratama JW, Chames P, Bolhuis RL (2000) Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther 7(16):1369\u20131377","journal-title":"Gene Ther"},{"issue":"1","key":"896_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-3-17","volume":"3","author":"C Yee","year":"2005","unstructured":"Yee C (2005) Adoptive T cell therapy: addressing challenges in cancer immunotherapy. J Transl Med 3(1):17","journal-title":"J Transl Med"},{"issue":"10","key":"896_CR16","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI488","volume":"101","author":"P Yotnda","year":"1998","unstructured":"Yotnda P, Firat H, Garcia-Pons F, Garcia Z, Gourru G, Vernant JP, Lemonnier FA, Leblond V, Langlade-Demoyen P (1998) Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest 101(10):2290\u20132296","journal-title":"J Clin Invest"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-012-0896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10529-012-0896-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-012-0896-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:03:34Z","timestamp":1559160214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10529-012-0896-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,24]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s10529-012-0896-5","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,24]]}}}